Regen BioPharma Inc Annual Interest Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regen BioPharma Inc quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
  • Regen BioPharma Inc Interest Expense for the quarter ending March 31, 2024 was $17.1K, a 41.2% increase year-over-year.
  • Regen BioPharma Inc Interest Expense for the twelve months ending March 31, 2024 was $64K, a 29.4% decline year-over-year.
  • Regen BioPharma Inc annual Interest Expense for 2023 was $58.6K, a 57.8% decline from 2022.
  • Regen BioPharma Inc annual Interest Expense for 2022 was $139K, a 56.1% decline from 2021.
  • Regen BioPharma Inc annual Interest Expense for 2021 was $316K, a 5.22% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $58.6K -$80.1K -57.8% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-20
2022 $139K -$177K -56.1% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-20
2021 $316K -$17.4K -5.22% Oct 1, 2020 Sep 30, 2021 10-K 2022-11-15
2020 $333K +$38.2K +13% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-22
2019 $295K +$36.1K +13.9% Oct 1, 2018 Sep 30, 2019 10-K 2021-08-04
2018 $259K +$160K +162% Oct 1, 2017 Sep 30, 2018 10-K 2021-06-21
2017 $98.8K +$71K +255% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-27
2016 $27.8K +$6.14K +28.3% Oct 1, 2015 Sep 30, 2016 10-K 2016-12-21
2015 $21.7K +$19.5K +880% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-21
2014 $2.21K +$2.21K Oct 1, 2013 Sep 30, 2014 10-K/A 2017-04-28
2013 $0 Oct 1, 2012 Sep 30, 2013 10-K 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.